AI, Ozempic & Recruitment: This Week's Healthcare Stories

Share
Share
Alice Williams, Schneider Electric’s VP of Digital Energy for UK&I
This week's top stories in the healthcare sector focus on innovations from Schneider Electric, the NHS, Cera, Google, GS1 and DeepHealth

How is Schneider Electric Making the NHS More Accessible?

In the case of hospitals, electrification and technology can bring sustainability and accessibility, as well as reducing costs and increasing patient autonomy.

Schneider Electric, the global leader in digital energy management and automation, is working with the NHS National Rehabilitation Centre (NRC) to deploy technology in pursuit of these benefits.

“We are incredibly proud to partner with the National Rehabilitation Centre on this landmark project,” says Alice Williams, Schneider Electric’s VP of Digital Energy for UK&I. 

“Delivering the NHS’s first building to meet NHS Net Zero Operational Building Standard is a testament to what’s possible when innovation, sustainability and patient care come together.”

WHO: The Crisis Risk of Global Shortages of Ozempic & Wegovy

Ozempic & Wegovy supplier, Novo Nordisk, warns of drug shortages until 2025

The World Health Organization (WHO) has issued its first global guidance on the use of weight loss injections like Ozempic and Wegovy, warning that fewer than one in ten people who could benefit are currently able to access them.

With more than one billion people worldwide now living with obesity, the WHO has urged governments and manufacturers to take immediate action to expand supply and cut costs.

The warning comes as obesity rates continue to climb toward projected levels of more than two billion people by 2030, placing immense strain on already overburdened health systems.

How DeepHealth is Using AI to Screen for Breast Cancer

DeepHealth's TechLive Command Center (Credit: DeepHealth)

DeepHealth, a RadNet company, has introduced the DeepHealth Breast Suite – a modular AI platform built to strengthen breast cancer detection, risk stratification and clinical workflow efficiency.

Building on the company’s proven imaging technology, the Breast Suite integrates tools from iCAD to deliver a unified AI environment supporting more than 10 million mammograms annually.

“The launch of Breast Suite marks a pivotal step toward a new, AI-powered standard of care in breast cancer screening and diagnostic pathways," says Kees Wesdorp, President and CEO of DeepHealth.

Google Lens & GS1 Boost Healthcare Transparency

GS1 has partnered with Google. Credit: GS1

Most of us barely glance at the tiny codes printed on medicine packs, but they are about to become a lot more useful. 

Through a new collaboration with GS1, the organisation behind the familiar barcode, Google Lens will let people scan GS1 DataMatrix codes on millions of existing medicine packs and instantly surface trusted information. 

The shift gives patients a simple way to understand what they are taking, helps shine a light on how medicines move through the healthcare system and supports safer, more transparent and more sustainable pharmaceutical practices.

How can AI Transform Recruiting in the Healthcare Sector?

Youtube Placeholder

The UK's health and social care sector is grappling with severe staffing challenges that threaten service delivery.

Healthcare company Cera reports approximately 110,000 vacancies in social care alone, whilst NHS workforce projections indicate potential shortages could reach 360,000 roles by 2036.

Conventional recruitment approaches, characterised by slow processing times, substantial resource demands and dependence on manual candidate screening, are proving inadequate to address the scale of this challenge.

Against this backdrop, Cera, one of the UK's largest home healthcare providers, has turned to artificial intelligence as a potential solution to transform how the sector approaches hiring.

Executives